EXHIBIT 10.9

ASSIGNMENT OF EMPLOYMENT AGREEMENT

ASSIGNMENT OF EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 17,
2007, by and among Trans-Pharma Corporation, a Nevada corporation
(“Trans-Pharma”), Transdel Pharmaceuticals, Inc., a Delaware corporation
(“Transdel”), and Juliet Singh, PhD (“Executive”).

WHEREAS, Trans-Pharma and Executive have entered into that certain Employment
Agreement, dated as of June 27, 2007 (the “Employment Agreement”);

WHEREAS, Trans-Pharma and Executive wish to assign Trans-Pharma’s obligations,
right, title, interest in, to and under the Employment Agreement to Transdel and
Transdel agrees to assume and accept such assignments and Executive consents to
such assignment.

NOW THEREFORE, Trans-Pharma, Transdel and Executive agree as follows:

1. Assignment and Assumption. Trans-Pharma does hereby assign (the “Assignment”)
unto Transdel all of its obligations, right, title, interest in, to and under
the Employment Agreement. Each of the undersigned consents to the Assignment.

2.  Ratification. Except as assigned hereby, nothing herein contained shall
otherwise modify, reduce, amend or otherwise supplement the terms and provisions
of the Employment Agreement, which shall remain in full force and effect in
accordance with its terms.

3. Governing Law. This Agreement shall be governed by, and be construed in
accordance with, the laws of the State of California.

4. Counterparts. This Agreement may be executed in one or more counterparts and
by the parties hereto in separate counterparts, each of which when executed
shall be deemed to be an original but both of which together shall constitute
one and the same Amendment.

[SIGNATURE PAGE FOLLOWS]

 
 

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, Trans-Pharma, Transdel, and Executive have executed this
Agreement as of the date first written above.

Trans-Pharma Corporation
   
By:
/s/ Juliet Singh, Ph.D.
 
Name: Juliet Singh, PhD
 
Title:   Chief Executive Officer
   
Transdel Pharmaceuticals, Inc.
   
By:
/s/ John T. Lomoro
 
Name: John T. Lomoro
 
Title:   Chief Financial Officer
   
Executive:
 
/s/ Juliet Singh, Ph.D.
Juliet Singh, PhD

 
 
 

--------------------------------------------------------------------------------